Comprehensive molecular analysis identifies eight novel variants in XY females with disorders of sex development
Molecular Human Reproduction · 2023
DOI: 10.1093/molehr/gaad001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Human Reproduction, 2023. Verfasst von Vinayak Kulkarni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India. Hauptthemen laut MEDLINE: Disorder of Sex Development, 46,XY, Gonadal Dysgenesis, 46,XY. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Indian Council of Medical Research, NIH.
Abstract (Originalsprache)
Disorders of sex development (DSD) are a group of clinical conditions with variable presentation and genetic background. Females with or without development of secondary sexual characters and presenting with primary amenorrhea (PA) and a 46,XY karyotype are one of the classified groups in DSD. In this study, we aimed to determine the genetic mutations in 25 females with PA and a 46,XY karyotype to show correlations with their phenotypes. Routine Sanger sequencing with candidate genes like SRY, AR, SRD5A2, and SF1, which are mainly responsible for 46,XY DSD in adolescent females, was performed. In a cohort of 25 patients of PA with 46,XY DSD, where routine Sanger sequencing failed to detect the mutations, next-generation sequencing of a targeted gene panel with 81 genes was used for the molecular diagnosis. The targeted sequencing identified a total of 21 mutations including 8 novel variants in 20 out of 25 patients with DSD. The most frequently identified mutations in our series were in AR (36%), followed by SRD5A2 (20%), SF1 (12%), DHX37 (4%), HSD17B3 (4%), and DMRT2 (4%). We could not find any mutation in the DSD-related genes in five (20%) patients due to complex molecular mechanisms in 46,XY DSD, highlighting the possibility of new DSD genes which are yet to be discovered in these disorders. In conclusion, genetic testing, including cytogenetics and molecular genetics, is important for the diagnosis and management of 46,XY DSD cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India.
- Department of Cytogenetics, ICMR-National Institute of Immunohematology, Mumbai, India.
- Bioinformatics Division, School of Biotechnology and Bioinformatics, D.Y. Patil Deemed to be University, Navi Mumbai, India.
ORCID-Profile: Babu Rao Vundinti
Förderung
- Indian Council of Medical Research
- NIH
Zitieren
APA
Kulkarni, V., Chellasamy, S. K., Dhangar, S., Ghatanatti, J., & Vundinti, B. R. (2023). Comprehensive molecular analysis identifies eight novel variants in XY females with disorders of sex development. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaad001
Vancouver
Kulkarni V, Chellasamy SK, Dhangar S, Ghatanatti J, Vundinti BR. Comprehensive molecular analysis identifies eight novel variants in XY females with disorders of sex development. Molecular Human Reproduction. 2023. doi:10.1093/molehr/gaad001
BibTeX
@article{Kulkarni2023,
author = {Kulkarni, Vinayak and Chellasamy, Selvaa Kumar and Dhangar, Somprakash and Ghatanatti, Jagdeeshwar and Vundinti, Babu Rao},
title = {Comprehensive molecular analysis identifies eight novel variants in XY females with disorders of sex development},
journal = {Molecular Human Reproduction},
year = {2023},
doi = {10.1093/molehr/gaad001}
}
EUVIMED